Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Queensland Health
Express Scripts

Generated: March 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040167

« Back to Dashboard

NDA 040167 describes DOXYLAMINE SUCCINATE, which is a drug marketed by Copley Pharm, LNK, Perrigo, Quantum Pharmics, Actavis Labs Fl Inc, and Par Pharm Inc, and is included in six NDAs. It is available from twenty-eight suppliers. Additional details are available on the DOXYLAMINE SUCCINATE profile page.

The generic ingredient in DOXYLAMINE SUCCINATE is doxylamine succinate; pyridoxine hydrochloride. There are fourteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the doxylamine succinate; pyridoxine hydrochloride profile page.
Summary for 040167
Ingredient:doxylamine succinate
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 040167
Suppliers and Packaging for NDA: 040167
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DOXYLAMINE SUCCINATE doxylamine succinate TABLET;ORAL 040167 ANDA L. Perrigo Company 0113-0441 N 0113-0441-64
DOXYLAMINE SUCCINATE doxylamine succinate TABLET;ORAL 040167 ANDA L. Perrigo Company 0113-0441 N 0113-0441-73

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:TABLET;ORALStrength25MG
Approval Date:Sep 18, 1996TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
US Department of Justice
US Army
Harvard Business School
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.